Aperio Group LLC grew its holdings in shares of Centene Co. (NYSE:CNC) by 8.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 103,657 shares of the company’s stock after buying an additional 8,387 shares during the period. Aperio Group LLC owned approximately 0.06% of Centene worth $11,078,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Creative Planning raised its position in shares of Centene by 128.9% during the fourth quarter. Creative Planning now owns 6,115 shares of the company’s stock worth $617,000 after purchasing an additional 3,444 shares during the period. Schwab Charles Investment Management Inc. raised its position in shares of Centene by 5.7% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 708,434 shares of the company’s stock worth $71,467,000 after purchasing an additional 38,185 shares during the period. State of Alaska Department of Revenue raised its position in shares of Centene by 75.0% during the fourth quarter. State of Alaska Department of Revenue now owns 30,987 shares of the company’s stock worth $3,124,000 after purchasing an additional 13,279 shares during the period. Regentatlantic Capital LLC raised its position in shares of Centene by 134.5% during the fourth quarter. Regentatlantic Capital LLC now owns 14,210 shares of the company’s stock worth $1,434,000 after purchasing an additional 8,150 shares during the period. Finally, Prospera Financial Services Inc acquired a new position in shares of Centene during the fourth quarter worth approximately $239,000. Hedge funds and other institutional investors own 76.39% of the company’s stock.
A number of brokerages have recently weighed in on CNC. Leerink Swann reaffirmed a “market perform” rating and set a $90.00 target price (down from $100.00) on shares of Centene in a research report on Tuesday, February 13th. Credit Suisse Group upped their target price on Centene from $110.00 to $112.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 7th. Zacks Investment Research lowered Centene from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 10th. ValuEngine raised Centene from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Finally, Morgan Stanley increased their price target on Centene from $118.00 to $126.00 and gave the company an “overweight” rating in a research report on Wednesday, February 7th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $113.63.
Centene (NYSE:CNC) last announced its quarterly earnings data on Tuesday, April 24th. The company reported $2.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.25. The firm had revenue of $13.19 billion during the quarter, compared to the consensus estimate of $13.33 billion. Centene had a return on equity of 15.69% and a net margin of 2.06%. The business’s revenue for the quarter was up 12.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.12 EPS. equities analysts expect that Centene Co. will post 7.05 EPS for the current year.
In other Centene news, EVP Keith H. Williamson sold 1,000 shares of the company’s stock in a transaction on Wednesday, May 2nd. The stock was sold at an average price of $115.00, for a total value of $115,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Michael F. Neidorff sold 250,000 shares of the company’s stock in a transaction on Thursday, April 26th. The shares were sold at an average price of $108.20, for a total value of $27,050,000.00. The disclosure for this sale can be found here. Insiders sold a total of 265,550 shares of company stock valued at $28,712,209 in the last 90 days. Corporate insiders own 3.00% of the company’s stock.
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.